We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$26.9B
AUM Growth
+$133M
Cap. Flow
-$722M
Cap. Flow %
-2.68%
Top 10 Hldgs %
41.71%
Holding
1,213
New
133
Increased
618
Reduced
406
Closed
45

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$383M
2
QCOM icon
Qualcomm
QCOM
+$171M
3
MU icon
Micron Technology
MU
+$156M
4
AVGO icon
Broadcom
AVGO
+$94.3M
5
ADI icon
Analog Devices
ADI
+$90.9M

Sector Composition

Rank Sector Weight
1 Technology 46.91%
2 Financials 9.57%
3 Healthcare 5.39%
4 Consumer Discretionary 3.89%
5 Energy 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQDA icon
1151
Liquidia Corp
LQDA
$7.72B
$142K ﹤0.01%
+11,841
New +$157K
LYFT icon
1152
Lyft
LYFT
$5.86B
$141K ﹤0.01%
10,023
-2,569
-20% -$41.7K
FLNA
1153
Filana Therapeutics
FLNA
$42M
$139K ﹤0.01%
11,257
+1,287
+13% +$27.1K
ETRN
1154
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$139K ﹤0.01%
+10,693
New +$143K
TDOC icon
1155
Teladoc Health
TDOC
$1.66B
$127K ﹤0.01%
13,032
-39,291
-75% -$479K
DFTX
1156
Definium Therapeutics
DFTX
$5.6B
$125K ﹤0.01%
+17,299
New +$151K
JBLU icon
1157
JetBlue
JBLU
$2.16B
$125K ﹤0.01%
20,474
-5,870
-22% -$35.4K
MASS icon
1158
908 Devices
MASS
$312M
$124K ﹤0.01%
+24,095
New +$145K
AMRX icon
1159
Amneal Pharmaceuticals
AMRX
$6.1B
$110K ﹤0.01%
17,247
+2,106
+14% +$13.4K
HSAI
1160
Hesai Group
HSAI
$2.57B
$99.5K ﹤0.01%
+23,735
New +$113K
ARKO icon
1161
ARKO Corp
ARKO
$868M
$98.7K ﹤0.01%
+15,742
New +$84.6K
EYPT icon
1162
EyePoint Inc
EYPT
$999M
$91.5K ﹤0.01%
10,514
-1,588
-13% -$22.2K
ALTM
1163
DELISTED
Arcadium Lithium plc
ALTM
$85.5K ﹤0.01%
+25,443
New +$106K
PSNY icon
1164
Polestar Automotive Holding UK
PSNY
$1.97B
$74.9K ﹤0.01%
3,172
+1,955
+161% +$65.3K
JOBY icon
1165
Joby Aviation
JOBY
$6.54B
$54K ﹤0.01%
10,587
-2,846
-21% -$14.2K
CRNC icon
1166
Cerence
CRNC
$359M
$47.7K ﹤0.01%
+16,867
New +$120K
NUVB icon
1167
Nuvation Bio
NUVB
$2.29B
$47.2K ﹤0.01%
+16,171
New +$49.3K
XERS icon
1168
Xeris Biopharma Holdings
XERS
$1.45B
$44K ﹤0.01%
19,536
-1,677
-8% -$3.38K
AI icon
1169
C3.ai
AI
$1.38B
-18,864
Closed -$511K
AMLX icon
1170
Amylyx Pharmaceuticals
AMLX
$2.19B
-53,201
Closed -$151K
AUR icon
1171
Aurora
AUR
$11.7B
-212,434
Closed -$599K
CMRC
1172
Commerce.com Inc Series 1
CMRC
$272M
-56,906
Closed -$392K
BLNK icon
1173
Blink Charging
BLNK
$67.5M
-58,617
Closed -$176K
BLUE
1174
DELISTED
bluebird bio
BLUE
-5,432
Closed -$139K
BMEA icon
1175
Biomea Fusion
BMEA
$88.2M
-478,367
Closed -$7.15M

Similar funds

Rafferty Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Rafferty Asset Management held 1,213 positions worth $26.9B, up 0.5% from $26.8B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Rafferty Asset Management's Q2 2024 filing shows 133 new, 618 increased, 406 reduced and 45 closed positions. Its largest new stake was KKR & Co: 234,082 shares worth $24.6M. The largest sale was Apple, an estimated $383M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 47% a quarter earlier, followed by Financials and Healthcare.

  • Rafferty Asset Management's largest Q2 2024 buy was KKR & Co: 234,082 shares worth $24.6M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2024, an estimated $383M increase.
  • Rafferty Asset Management's biggest Q2 2024 reduction was Apple, cutting an estimated $383M.
  • Rafferty Asset Management fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $55.8M.
  • Rafferty Asset Management's ten largest holdings make up 42% of its $26.9B portfolio in Q2 2024.
  • Rafferty Asset Management opened 133 new positions and closed 45 in Q2 2024.
  • Rafferty Asset Management's portfolio value rose 0.5% quarter-over-quarter to $26.9B.

Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.